CONTACT LENSES TODAY
February 19, 2006
Contact Lenses Today® is edited by Dr. Joseph T. Barr and the staff of Contact Lens Spectrum. This week CLToday® reaches more
than 12,000 readers in 74 countries.
B&L Teams With Novartis To Promote Retisert
Bausch & Lomb and Novartis Ophthalmics will co-promote B&L’s Retisert 0.59mg (fluocinolone acetonide intravitreal implant), indicated for
the treatment of chronic, noninfectious, posterior segment uveitis. The Novartis retinal sales team will promote Restisert to its network of retinal specialists in the
U.S., supplementing the efforts of B&L's’ pharmaceutical sales team.
Rose K2 Offers Advanced Aberration Control
Blanchard Contact Lens’ ne